CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

Nitric oxide bioavailability

Novel & Emerging BiomarkersLab test / biomarkerprotectivepartially modifiable
17
evidence score

Also known as: Nitric oxide production/bioavailability impairment, decreased nitric oxide (NO•) bioavailability, nitric oxide, nitric oxide production

PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 7meta-analyses: 0trials: 9.5genetic: 0MR bonus:

References (4)

0 meta-analyses / systematic reviews

Clinical trials (8)

NCTTitleStatusTypeInterventions
NCT06657976Response to Exercise and Nitric Oxide in Peripheral Artery Disease: The RESIST PAD TrialRECRUITINGINTERVENTIONALSupervised Treadmill Exercise, Attention Control, Nitrate-Rich Beetroot Juice + supervised exercise therapy
NCT04800692The Effects of ATLAS (Arginine Tetrahydrobiopterin L-Ascorbate) Therapy on Nitric Oxide Bioavailability and Pain-free Walking in Patients With Intermittent ClaudicationACTIVE NOT RECRUITINGINTERVENTIONALTetrahydrobiopterin 10 mg/kg, Tetrahydrobiopterin 20 mg/kg, L-Ascorbate
NCT03534661Role of a Nitric Oxide Synthase Inhibitor on GLP-2 Mediated Intestinal Lipoprotein ReleaseCOMPLETEDINTERVENTIONALTeduglutide + Normal Saline, Teduglutide + L-NMMA, Placebo + L-NMMA
NCT04179942Fractional Exhaled Nitric Oxide and CRP Levels in Egyptian Patients With Obstructive Sleep Apnea SyndromeCOMPLETEDINTERVENTIONALFractional exhaled nitric oxide and CRP levels
NCT01802619Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass: A Double Blind Randomized Controlled Trial.COMPLETEDINTERVENTIONALinhaled nitric oxide, inhaled Nitrogen
NCT00981591A Randomized, Double Blind, Placebo-controlled Pilot Study of the Safety and Effective Dosing of Inhaled Iloprost in Pediatric Patients With Pulmonary Hypertension Treated With Inhaled Nitric OxideWITHDRAWNINTERVENTIONALIloprost, Placebo
NCT00782652The Effects of Nitric Oxide for Inhalation on Survival or the Need for Dialysis or a Right Ventricular Assistance Device (RVAD) in Right Ventricular Infarction PatientsTERMINATEDINTERVENTIONALinhaled nitric oxide, nitrogen gas
NCT00160745A Randomised, Double-blind, Placebo-controlled, Mono-centre, Explorative Phase II Trial to Study the Effects of Rosuvastatin on Basal Production and Release of Nitric Oxide From the Renal Vasculature in Patients With Hypercholesterolemia.COMPLETEDINTERVENTIONALRosuvastatin

Genetic associations (0)

None linked.